Dec 062016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– FRANCE, Grenoble – PDC*line Pharma, a company developing a new immuno-oncology platform, today announces a first funding round of €4M ($4.24M), including €2.6M ($2.76M) in capital and €1.4M ($1.48M) in bank loans, grants and recoverable advances.… => Read more

PDC*line Pharma appoints Eric Halioua to its Board as CEO along with raising €4m financing

From:: PDC*line Pharma appoints Eric Halioua to its Board as CEO along with raising €4m financing

Sorry, the comment form is closed at this time.

%d bloggers like this: